PhRMA's Steve Ubl to step down by year-end, triggering CEO search

Steve Ubl, CEO of the Pharmaceutical Research and Manufacturers of America, will depart at the end of the year after a decade leading the branded-drug lobby, leaving a leadership gap as Congress pressures lower drug costs and the administration pursues pricing reforms. The board will search for a successor, with Ubl remaining through a smooth transition; Lori Reilly is considered a leading internal candidate as PhRMA navigates IRA-era price negotiations and rising industry scrutiny.